Abortion in First Trimester Clinical Trial
Official title:
Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion: A Blinded Randomized Controlled Trial
Verified date | October 2020 |
Source | Stanford University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
High-frequency, high-intensity transcutaneous electrical nerve-stimulation (TENS) is an inexpensive and non-invasive pain control approach. TENS, pulsating electrical currents that activate underlying nerves, does not have drug interactions or risk of overdose. Cochrane review of TENS for acute pain found inconclusive evidence. One previous abortion trial comparing TENS to IV sedation only looked at pain control in the recovery room. The investigators propose a randomized controlled trial comparing TENS to IV sedation (in conjunction with local anesthesia) among women presenting for first-trimester surgical abortion. Primary outcome will be perceived pain by Visual Analogue Scale (VAS) during aspiration.
Status | Completed |
Enrollment | 109 |
Est. completion date | October 31, 2019 |
Est. primary completion date | October 31, 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion criteria: - Presenting for surgical abortion - Gestational age <12 weeks - < 18 years of age - Agrees to be randomized Exclusion criteria: - Allergy to study medications (lidocaine, fentanyl, midazolam) - > 18 years of age - Fetal demise - Pre-procedure use of misoprostol - No means of transportation following procedure |
Country | Name | City | State |
---|---|---|---|
United States | Planned Parenthood Mar Monte | San Jose | California |
Lead Sponsor | Collaborator |
---|---|
Stanford University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Aspiration Pain | Pain with aspiration, assessed by visual analogue scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") | Intraoperative, collected during procedure at the time of aspiration (up to 30 seconds) | |
Secondary | Speculum Placement Pain | Pain with speculum placement, assessed by visual analog scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") | Intraoperative, collected during procedure (up to 30 seconds) | |
Secondary | Tenaculum Placement Pain | Pain at time of tenaculum placement, assessed by visual analog scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") | Intraoperative, collected during procedure (up to 30 seconds) | |
Secondary | Paracervical Block Pain | Pain with paracervical block, assessed by visual analog scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") | Intraoperative, collected during procedure (up to 30 seconds) | |
Secondary | Manual Cervical Dilation Pain | Pain with manual cervical dilation, assessed by visual analog scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") | Intraoperative, collected during procedure (up to 30 seconds) | |
Secondary | Speculum Removal Pain | Pain with speculum removal, assessed by visual analog scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") | Intraoperative, collected during procedure (up to 30 seconds) | |
Secondary | Total Procedure Time | Time from speculum placement to speculum removal, measured in minutes | Intraoperative, collected during procedure (up to 20 minutes) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04056637 -
Choice of Modality of Follow up for Medication Abortion
|
N/A | |
Active, not recruiting |
NCT05896657 -
Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713
|
N/A | |
Active, not recruiting |
NCT03736681 -
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage
|
Phase 1 | |
Completed |
NCT03636451 -
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o
|
Phase 3 | |
Completed |
NCT04446572 -
Application of Lactobacillus Salivarius CECT5713 in Infertility of Unknown Origin
|
Phase 2 | |
Not yet recruiting |
NCT03267771 -
Progesterone and Doppler in Recurrent Abortion
|
Phase 4 | |
Recruiting |
NCT05341817 -
The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy
|
Phase 4 | |
Completed |
NCT03079622 -
Manual Versus Electric Vacuum Aspiration for Pregnancy Termination Between 10-14 Weeks
|
N/A | |
Recruiting |
NCT05182008 -
A Patient Decision Aid for Method of Early Abortion: A Randomized Control Trial
|
N/A | |
Completed |
NCT03417362 -
Delivery of Audiovisual Information on Early Medical Abortion
|
N/A | |
Completed |
NCT03896022 -
Auriculotherapy - Pain Management of Aspiration Abortion
|
N/A | |
Completed |
NCT03925129 -
Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation
|
N/A | |
Suspended |
NCT03751423 -
Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion
|
Phase 3 | |
Completed |
NCT03480009 -
Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion
|
Phase 3 | |
Completed |
NCT05469594 -
Second-trimester TOP : a Retrospective Study Comparing Complications at 12-14 vs 14-16 Weeks of Gestation
|
||
Completed |
NCT05320432 -
Transcutaneous Electrical Nerve Stimulation for Pain Control During First-trimester Abortion
|
N/A | |
Terminated |
NCT04139382 -
Using Telemedicine to Improve Early Medical Abortion at Home
|
N/A | |
Recruiting |
NCT04956731 -
Pharmacist Provision of Medication Abortion
|
N/A | |
Recruiting |
NCT04336358 -
Telemedicine for First Trimester Abortion in South Africa
|
N/A | |
Completed |
NCT02096575 -
Nitrous Oxide for Pain Management of First Trimester Surgical Abortion
|
N/A |